Back to search results

Acupuncture Study for People At High Risk for Sepsis

This study is looking into whether acupuncture can help people at high risk for sepsis. Sepsis is a life-threatening response to an infection. Researchers will compare real acupuncture, which uses thin needles at specific body points, to sham acupuncture, where a needle is taped to the skin at a non-acupuncture point. You might be able to join if you are 18 or older and have recently had a sepsis order placed by a doctor. The study aims to see how many people complete the treatment and if acupuncture can reduce the need for admission to the intensive care unit (ICU) within 30 days. The current status of the study is unclear, and it plans to enroll 78 participants.

Study design
This is an interventional study comparing real acupuncture to sham acupuncture. It plans to enroll 78 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 2 years to see how many complete the study treatment, and for 30 days to check for ICU admission or transfer.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06344819

An Acupuncture Study for People At High Risk for Sepsis

Recruiting
PHASE2Ages 18+InterventionalTreatment
University of California, Irvine
~78 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:AcupunctureSham Acupuncture

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants recruited compared to the number of participants who complete study treatment.
Measured over Up to 2 years
+1 more outcome measured

Conditions

Sepsis

Explore related trials

Septicemia

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Gary Deng, MD, PhD · PRINCIPAL_INVESTIGATOR · University of California, Irvine

Who to contact

Gary Deng, MD, PhD
[email protected]
949-824-7000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 or older
Having a sepsis order-set placed within the previous 48 hours

Exclusion

The study Principal Investigator will review the medical record again prior to enrollment to exclude non-sepsis patients (Even though the placement of sepsis order set already screens out such patients, subsequent clinical development after sepsis order set placement may generate new information that deems the patient not septic.)
Admitted to ICU before being approached for consenting
Having an implanted medical device, such as a pacemaker or implantable cardioverter-defibrillator (ICD), with which electroacupuncture
Unable to obtain informed consent due to a participant's mental status and absence of an individual authorized to give consent on the participant's behalf
The patient is on an interventional clinical trial and its Principal Investigator does not give approval to enrollment to this study (e.g. genomic profiling, biospecimen, or observational studies do not require PI approval).

What this trial measures

  • Number of participants recruited compared to the number of participants who complete study treatment.Up to 2 years

    To assess the feasibility of conducting a randomized controlled trial of acupuncture in hospitalized patients who are at risk for sepsis.

  • Admission/transfer to ICUWithin 30 days

    Deterioration of a participant's clinical condition that necessitate an admission or transfer to an Intensive Care Unit (ICU)